Abiopharma

🔍 OLIVER ERIC L (Executive)

Company: CROSS TIMBERS ROYALTY TRUST (CRT)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 3,087 shares of Units of Beneficial Interest at $10.12 per share (Direct)
  Date: 2026-08-13 | Code: P | equity_swap_involved: 0 | shares_owned_after: 954,129.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 9,609 shares of Units of Beneficial Interest at $10.44 per share (Direct)
  Date: 2026-08-14 | Code: P | equity_swap_involved: 0 | shares_owned_after: 963,738.00 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.00 to $10.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within such range.
• F2: Directly held by SoftVest, LP. SoftVest GP I, LLC is the general partner of SoftVest, LP and Eric L. Oliver is the managing member of SoftVest GP I, LLC. As a result, each of SoftVest GP I, LLC and Mr. Oliver may be deemed to beneficially own the securities beneficially owned by SoftVest, LP. Mr. Oliver disclaims any beneficial ownership with respect to the securities held by SoftVest, LP except to the extent of his pecuniary interest therein.
• F3: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.35 to $10.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within such range.